ESSE-RF study: epidemiology and public health promotion

Концевая, А. В.; Шальнова, С. А.; Драпкина, О. М.

doi:10.15829/1728-8800-2021-2987

Cited by 14 publications

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Доля лиц, ведущих здоровый образ жизни, в России в 2020г составляет 9,1%, со значительной региональной вариабельностью. Этот показатель с течением времени снижается с 12 (2019г) до 9,1% (2020г) в целом по стране [12]. Для формирования у работников желания вести здоровый образ жизни необходимо их постоянное информирование о преимуществах здорового образа жизни при помощи различных средств коммуникации.…”

Section: Discussionunclassified

Experience in implementing workplace wellbeing programs in Russia: results of a survey of employers on the ATRIA platform

Анциферова¹,

Kontsevaya²,

Khudyakov³

et al. 2022

Cardiovasc Ther Prev

Self Cite

View full text Add to dashboard Cite

One of the effective approaches to the prevention of noncommunicable diseases and the extension of labor potential is the introduction of workplace wellbeing programs (WWPs). The implementation of WWPs and the formation of health promotion working conditions contribute to improvement of the wellbeing and quality of life of employees, reduce presenteeism, absenteeism and improve the economic performance of the company.Aim. To assess the experience of implementing the WWPs among employers in Russia using the ATRIA electronic platform.Material and methods. Experts from the National Medical Research Center for Therapy and Preventive Medicine have developed a set of tools (a questionnaire for employers and employees) to assist in the development and implementation of WWPs. A link to an ATRIA electronic platform was sent to the chief external specialists in preventive medicine to ensure a wide coverage of the country’s population. The survey was conducted from April 2020 to October 2021.Results. The survey involved 181 employers and 7500 employees (women, 63,2%, n=4735), but not every respondent answered all questions. The companies related to education, science and culture (23,8%, n=43), metallurgy/mining (19,9%, n=36) and chemical/ petrochemical industry (11,6%, n=21). The majority of employers (73%; n=73) consider it necessary to develop and implement WWPs, while the majority of them (66,9%, n=121) were not familiar with such programs. Companies mainly implement health examinations (79,4%, n=100), vaccination (78,6%, n=99), measures aimed at increasing the physical activity (73,8%, n=93). Only 50% of employers evaluate the effectiveness of WWPs: according to a survey of employees — 41,2% (n=47), according to temporary disability rate — 27,2% (n=31), according to staff turnover — 13,2% (n=15). Through the implementation of the WWPs, employers expect to improve employee health (94,4%, n=171), employee satisfaction (81,2%, n=147), morale (77,3%, n=140) and workforce productivity (75,1%, n=136).Conclusion. The prevalence of WWPs in Russia varies depending on the industry, the entities involved in its implementation, the nature of work and the number of employees, which creates health inequalities and justifies the need to develop targeted interventions and measures to implement WWPs.

show abstract

Section: Discussionunclassified

Experience in implementing workplace wellbeing programs in Russia: results of a survey of employers on the ATRIA platform

Анциферова¹,

Kontsevaya²,

Khudyakov³

et al. 2022

Cardiovasc Ther Prev

Self Cite

View full text Add to dashboard Cite

show abstract

“…У тех, кто был привержен к здоровому образу жизни кумулятивная летальность была существенно ниже -на 39%. Данные Росстата за 2020 год, что соответствует пандемии COVID-19, фиксируют уменьшение до 9,1% приверженных к ЗОЖ [7]. Медикаментозное воздействие на ФР в Российском обществе, которое должно осуществляться в виде долговременного систематического применения таблетированных лекарственных препаратов, также мало распространено.…”

Section: резюмеunclassified

Polypill as a means of population pharmacological prevention of cardiovascular diseases

Lebedev,

Petruhina,

Paranina

2024

ECG

View full text Add to dashboard Cite

Non-communicable diseases, among which arterial hypertension and ischemic heart disease are the predominant contributors to disability and mortality, have long been identified as a strategic target of preventive intervention in our country. The situation is aggravated by covid-19 associated mortality, which is characterized by delayed dynamics and is largely related to cardiovascular. Excess mortality, in the structure of which cardiovascular diseases are leading, requires new solutions. One of them is population pharmacoprevention, based on the use of complex fixed combinations of drugs targeting different risk factors, as arterial hypertension and dyslipidemia, as most important. This concept, which logically follows from modern realities, is in contradiction with the existing approach of personalized therapy in high/very high risk groups, because of its complexity, leading to patients noncompliance. The new system of cardiovascular risk stratification SCORE 2 introduced in the Russian Federation significantly contributes to the spread of the concept of polypills as a unified approach primarily in the most vulnerable population of males 50 years and older.

show abstract

“…Исследование ЭССЕ-РФ также показало, что сердечно-сосудистая смертность в РФ определяется в наибольшей степени вкладом АГ (35%), при этом наибольший экономический ущерб от ФР также ассоциируется с АГ (869,9 млрд руб. -1,01% валового внутреннего продукта) [8]. При этом наихудшие показатели по риску смерти имеют пациенты с АГ, принимающие лекарственную терапию, но не достигающие целевых значений АД [9], что постулирует необходимость тщательного контроля эффективности назначенной пациенту антигипертензивной терапии.…”

unclassified

Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation)

Кашталап

2022

Russ J Cardiol

View full text Add to dashboard Cite

The article presents epidemiological data on the high prevalence of hypertension and dyslipidemia comorbidity in the general population, as well as shows the leading role of these key cardiovascular risk factors in the development of cardiovascular events. At the same time, within the primary prevention, the adherence of patients to the lipid-lowering therapy remains low. Fixed-dose combinations (Lipertans) based on antihypertensive (amlodipine, perindopril) and lipid-lowering drugs (atorvastatin) can significantly increase the effectiveness of therapy.

show abstract

ESSE-RF study: epidemiology and public health promotion

Cited by 14 publications

References 22 publications

Experience in implementing workplace wellbeing programs in Russia: results of a survey of employers on the ATRIA platform

Experience in implementing workplace wellbeing programs in Russia: results of a survey of employers on the ATRIA platform

Polypill as a means of population pharmacological prevention of cardiovascular diseases

Therapy for hypertension and dyslipidemia: potential of Lipertans (on the example of a clinical observation)

Contact Info

Product

Resources

About